FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2873105251> ?p ?o ?g. }

• W2873105251 endingPage "224" @default.
• W2873105251 startingPage "218" @default.
• W2873105251 abstract "Aim: Based on the response criteria of the 2015 American Thyroid Associations guidelines, our objectives were to determine the response rate when using a low dose of 131-I GBq in patients with low-risk differentiated thyroid cancer (LRDTC) and the influence of clinical and analytical variables on the prediction of complete response. Methods: We performed a multicentre and longitudinal study, including patients who were operated for LRDTC and who underwent radioiodine remnant ablation with a low-dose of 131-I. All patients were assessed at 6–12 months, and their status was classified as complete (excellent response) or incomplete response (structural incomplete, biochemical incomplete or indeterminate response). Various factors including age, gender, histology, tumour focality and size, stage, time from surgery to treatment, type of thyroid-stimulating hormone (TSH) stimulation, preablation serum thyroglobulin (pTg), antiTg antibodies (pAntiTgAb) and TSH (pTSH) levels were also analysed in order to predict the complete response rate. Results: Of 108 patients, 79.6% achieved complete response and the remaining showed incomplete response (2.9, 5.5 and 12% due to biochemical incomplete, structural incomplete and indeterminate response respectively). Six patients received a new dose of 131-I. Tumour size and pAntiTgAb were the only factors related to therapeutic response (p = 0.03 and p < 0.01, respectively). However, pAntiTgAb was the only independent factor related to complete response. Patients with complete response showed lower pTg than those with incomplete response (5.1 ± 12.9 vs. 11.2 ± 25 ng/mL) although without statistical significance (p = 0.14). There was no significant difference in the response rate depending on the thyrotropin stimulation methods. Conclusions: A low dose of 131-I was sufficient for reaching a complete response at 6–12 months of follow-up in the majority of patients with LRDTC. Tumour size and pAntiTgAb variables were related to therapeutic response." @default.
• W2873105251 created "2018-07-19" @default.
• W2873105251 creator A5017647793 @default.
• W2873105251 creator A5020749669 @default.
• W2873105251 creator A5029017319 @default.
• W2873105251 creator A5033273497 @default.
• W2873105251 creator A5036879989 @default.
• W2873105251 creator A5037657845 @default.
• W2873105251 creator A5053903107 @default.
• W2873105251 creator A5056188696 @default.
• W2873105251 creator A5064332587 @default.
• W2873105251 creator A5066830090 @default.
• W2873105251 date "2018-01-01" @default.
• W2873105251 modified "2023-09-26" @default.
• W2873105251 title "Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer" @default.
• W2873105251 cites W1966018225 @default.
• W2873105251 cites W1966235198 @default.
• W2873105251 cites W1967360230 @default.
• W2873105251 cites W1971085966 @default.
• W2873105251 cites W1971364283 @default.
• W2873105251 cites W1976508083 @default.
• W2873105251 cites W1989090451 @default.
• W2873105251 cites W1992679238 @default.
• W2873105251 cites W1994641629 @default.
• W2873105251 cites W2009838593 @default.
• W2873105251 cites W2011479095 @default.
• W2873105251 cites W2018120261 @default.
• W2873105251 cites W2019014309 @default.
• W2873105251 cites W2029563033 @default.
• W2873105251 cites W2029645261 @default.
• W2873105251 cites W2030494299 @default.
• W2873105251 cites W2034542445 @default.
• W2873105251 cites W2053272999 @default.
• W2873105251 cites W2058360842 @default.
• W2873105251 cites W2067095180 @default.
• W2873105251 cites W2093212431 @default.
• W2873105251 cites W2097812157 @default.
• W2873105251 cites W2100457651 @default.
• W2873105251 cites W2107717011 @default.
• W2873105251 cites W2110829017 @default.
• W2873105251 cites W2112027306 @default.
• W2873105251 cites W2126365735 @default.
• W2873105251 cites W2145150141 @default.
• W2873105251 cites W2145240320 @default.
• W2873105251 cites W2147485846 @default.
• W2873105251 cites W2169070974 @default.
• W2873105251 cites W2326897443 @default.
• W2873105251 cites W2329053744 @default.
• W2873105251 cites W2536889135 @default.
• W2873105251 cites W2606629527 @default.
• W2873105251 cites W2618004585 @default.
• W2873105251 cites W46820494 @default.
• W2873105251 cites W91247843 @default.
• W2873105251 doi "https://doi.org/10.1159/000489850" @default.
• W2873105251 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6140604" @default.
• W2873105251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30283741" @default.
• W2873105251 hasPublicationYear "2018" @default.
• W2873105251 type Work @default.
• W2873105251 sameAs 2873105251 @default.
• W2873105251 citedByCount "8" @default.
• W2873105251 countsByYear W28731052512019 @default.
• W2873105251 countsByYear W28731052512020 @default.
• W2873105251 countsByYear W28731052512023 @default.
• W2873105251 crossrefType "journal-article" @default.
• W2873105251 hasAuthorship W2873105251A5017647793 @default.
• W2873105251 hasAuthorship W2873105251A5020749669 @default.
• W2873105251 hasAuthorship W2873105251A5029017319 @default.
• W2873105251 hasAuthorship W2873105251A5033273497 @default.
• W2873105251 hasAuthorship W2873105251A5036879989 @default.
• W2873105251 hasAuthorship W2873105251A5037657845 @default.
• W2873105251 hasAuthorship W2873105251A5053903107 @default.
• W2873105251 hasAuthorship W2873105251A5056188696 @default.
• W2873105251 hasAuthorship W2873105251A5064332587 @default.
• W2873105251 hasAuthorship W2873105251A5066830090 @default.
• W2873105251 hasBestOaLocation W28731052511 @default.
• W2873105251 hasConcept C121608353 @default.
• W2873105251 hasConcept C126322002 @default.
• W2873105251 hasConcept C126894567 @default.
• W2873105251 hasConcept C134018914 @default.
• W2873105251 hasConcept C2776694085 @default.
• W2873105251 hasConcept C2778835679 @default.
• W2873105251 hasConcept C2778902805 @default.
• W2873105251 hasConcept C2779761222 @default.
• W2873105251 hasConcept C2989005 @default.
• W2873105251 hasConcept C3019096185 @default.
• W2873105251 hasConcept C526584372 @default.
• W2873105251 hasConcept C71315377 @default.
• W2873105251 hasConcept C71924100 @default.
• W2873105251 hasConcept C90924648 @default.
• W2873105251 hasConceptScore W2873105251C121608353 @default.
• W2873105251 hasConceptScore W2873105251C126322002 @default.
• W2873105251 hasConceptScore W2873105251C126894567 @default.
• W2873105251 hasConceptScore W2873105251C134018914 @default.
• W2873105251 hasConceptScore W2873105251C2776694085 @default.
• W2873105251 hasConceptScore W2873105251C2778835679 @default.
• W2873105251 hasConceptScore W2873105251C2778902805 @default.
• W2873105251 hasConceptScore W2873105251C2779761222 @default.
• W2873105251 hasConceptScore W2873105251C2989005 @default.

• next